IntraMed - Artículos - La Biopsia del Ganglio Centinela en Cáncer de Mama. Resultados de un estudio de 106 pacientes.
Premio bianual 2000 - 2001 de la Sociedad Argentina de Mastología | 29 MAY 02
La Biopsia del Ganglio Centinela en Cáncer de Mama. Resultados de un estudio de 106 pacientes.
La linfadenectomía axilar es parte fundamental del tratamiento quirúrgico del cáncer de mama aunque últimamente su aplicación rutinaria es cuestionada.
Autor: Dres. Loza J, Coló F y col * Fuente: Artículo Original  
Bibliografía

1. National Institute of Health Consensus Conference. Treatment for early stage breast cancer. Jama 1991;265:391-395.

2. Fisher B, Slak N, Katrich D et al. Ten years follow-up results of patient with carcinoma of the breast in a cooperative clinical trial evaluating surgical adyuvant chemotherapy. Surg Gynecol Obstet 1975;140:528-534.

3. Bonadonna G, Valagussa P, Moliterni A, et al. Adjuvant cyclophosphamide, methotrexate and fluoracil in node positive breast cancer: the results of 20 years  of follow-up. N Engl J Med 1995;332:901-906.

4. Kinne D. Controversies in primary breast cancer management. Am J Surg 1993;166:502-508.

5. Baxter N, Mc Cready D, Chapman J et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol 1996;3:235-240.

6. Fisher B, Redman C, Fischer E. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl  J Med 1985;312:674-681.

7. Early Breast Cancer Trialists´Cooperative Group. Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 1995;333:1444-1455.

8. White RE, Vezeridis MP, Konstadoulakis M, et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996;183:575-582.

9. Cabanes PA, Salamon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-1248.

10. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer. J Clin Oncol 1993;11:1536-1544.

11. Mustafa IA, Bland KL. Indications for axillary dissection in T1 breast cancer. Ann Surg Oncol 1998;5:4-8.

12. Maunsell E, Brisson J, Deshenes L, et al. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-316.

13. Hladiuk M, Huchcroft S, Temple W, et al. Arm function after axillary  dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992;50:47-52.

14. Wamuth M, Bowen G, Ghu L, et al. Complications of axillary lymph node dissections for carcinoma of the breast. Cancer 1998;83:1362-1368.

15. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301-308.

16. Singletary SE. Managment of the axilla in early stage breast cancer. In American Society of Clinical Oncology 34º annual meeting;1998 May 16-18; Los Angeles (Cal). Asco Educational Book; Spring 1998:132.141.

17. Anderson I, Aspergren K, Janzon L, et al. Mammographic screening and mortality from breast cancer. The Malmo mammographic screening trial. Br Med J 1988;297:943-948.

18. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.

19. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel node lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.

20. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.

21. Borgstein PJ, Meijer S, Pijper R, et al. Intradermal blue dye to identify sentinel lymph  node in breast cancer. Lancet 1997;349:1668-1669.

22. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.

23. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph node. Lancet 1997;349:1864-1867.

24. Guenther JM, Krishnammoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed car setting. Cancer J Sci Am 1997;3:336-340.

25. Pijpers R, Hoekstra OS, Collet GJ, et al. Impact of lymphoscintigraphy  on sentinel node identification with technetium 99m-coloidal albumin in breast cancer. J Nucl Med 1997;38:366-368.

26. Roumen RM, Valkenburg JG, Geuskens LM et al. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997;23:495.502.

27. Galimberti V, Zurrida S, Zucali P, et al. Can sentinel node biopsy avoid axillary cancer patients?. Breast 1998;7:8-10.

28. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-283.

29. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.

30. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-130.

31. Krag DN, Ashikaga T, Harlow SP, et al. Development of sentinel node targeting technique in breast cancer patients. Breast 1998;4:67-74.

32. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast cancer staging using lymphatic mapping with radiolabeled Dextran. Cancer 1998;82:1704-1708.

33. Flett MM, Going JJ, Stanton PD, et al. Sentinel node localization in  patient with breast cancer. Br J Surg 1998;85:991-993.

34. Crossin JA, Johnson AC, Stewart PB, et al. Gamma probe guided resection of the sentinel node in breast cancer. Am Surg 1998;64:666-669.

35. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941-946.

36. Liberman L, Cody III H, Hill A, et al. Sentinel lymph node biopsy after percutaneus diagnosis of nonpalpable breast cancer. Radiology 1999;211:835-844

37. Loza J, Colo F, Sporn V, et al. Biopsia del ganglio centinela. Una técnica para evitar la linfadenectomía en pacientes con cáncer de mama axila negativa. Rev Arg Mastol 1996;49:202-211.

38. Loza J, Colo F, Sporn V, et al. Biopsia del ganglio centinela. Una nueva alternativa en el manejo quirúrgico del cáncer de la mama. Oncol Clin 1999;4:144-147.

39. Del Castillo R, Garello N, Clavijo J, et al. Cáncer de mama: detección del ganglio centinela. Nuevas Tendencias en Oncología, (supl) 2000;9:abstract Nº1.25.

40. Noblia C, Cresta Morgado C, Gonzalez E, et al. Ganglio centinela en cáncer de mama. Experiencia del Instituto de Oncología Angel H. Roffo. Universidad de Buenos Aires. Rev Arg Mastol 1999;18(61):317-331.

41. Gago F, Tello O, Mendiondo B, et al. Evaluación de la técnica de identificación del Ganglio Centinela con azul patente en el cáncer de mama. Nuevas Tendencias en Oncología. (Supl) 2000;9:abstract Nº 1.13.

42. Barbera L, Terrier F, Illanes L, et al. Desarrollo y aplicación de un programa de aprendizaje de la técnica del ganglio centinela. Nuevas Tendencias en Oncología (Supl) 2000;9:Abstract Nº 1.09.

43. Borghi L, Peña F, Gomez Rueda N, et al. Estudio del ganglio centinela en tumores mamarios menores de 2 cm. Nuevas Tendencias en Oncología (Supl)2000;9:Abstract Nº 1.20.

44. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.

45. Morton D, Wen D, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.

46. Haigh P, Brennan M, Giuliano A. Surgery for diagnosis and treatment: sentinel lymph node biopsy in breast cancer. Cancer Control;JMCC 6(3):301-306,1999.

47. Glass E, Essner R, Giuliano A. Sentinel nodes localization in breast cancer. Semin Nucl Med 1999;29:57-68.

48. Cox CE, Pendas S, Cox JM, et al. Guidlines for sentinel node biopsy  and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-653.

49. Cox C, Bass S, McCann C, Wang M, et al. Learning curves for sentinel lymphatic mapping in breast cancer based on surgical volume analysis. Abstract 76. 53 Annual Cancer Symposium Society of Surgical Oncology. March 16-19 2000. New Orleans.

50. Ciucci JL, Zalazar J, Marcovecchio L. El sistema linfático de la glándula mamaria en relación con las indicaciones quirúrgicas actuales. Premio Avelino Gutierrez 1993. Academia Nacional de Medicina.

51. Saphir O, Amromin GD. Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1948;l:238-241.

52. Pickren JW. Significance of occult metastases. A study of breast cancer. Cancer l961;14:1266-1271.

53. Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer l978;42:2025-2031.

54. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node metastases from breast cancer. Lancet 1990;335:1565-1568.

55. Jannink I, Fan M, Nagy S, et al. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol 1998;5(4):310-314.

56. Dowlatshahi K, Fan M, Bloom K, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. Cancer 1999;86:990-996.

57. Giuliano AE. Current status of sentinel lymph node dissection in breast cancer. In American Society of Clinical Oncology 36º Annual Meeting; May 2000;New Orleans. Asco Educational Book; Spring 2000:238-243.

58. Gulec S, Moffat F, Carroll R, et al. Sentinel lymph node localization in early breast cancer. J Nucl Med 1998;39:1388-1393.

 

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014